Reduced muscarinic cholinoceptor density and sensitivity in various models of experimental cardiac hypertrophy
Authors:
- M. PfaffendorfMPM. Pfaffendorf
- P. A. van ZwietenPZP. A. van Zwieten
- 1 December 1995
- journal article
- Published by Wiley in Journal of Autonomic Pharmacology
- Vol. 15 (6) , 465-474
Abstract
1. In the present study we investigated functional and binding characteristics of muscarinic receptors in experimental cardiac hypertrophy. 2. As models of cardiac hypertrophy we used hearts of spontaneously hypertensive rats (SHR) and Wistar rats with surgically induced abdominal aorta stenosis (ASR). Wistar Kyoto rats (WKY) and sham operated Wistar rats were used as respective controls. 3. The hypertrophy was more pronounced in hearts of ASR compared to SHR, although the mean arterial pressure was found to be lower. 4. Isolated, perfused Langendorff heart preparations (paced with 5 Hz) from both groups of hypertrophied hearts were less sensitive to the muscarinic agonists oxotremorin and methacholine (P < 0.05, all n = 6) when compared with control organs. The maximal reduction in contractile force induced by methacholine was 59.3 +/- 4.5% in SHR and 41.6 +/- 3.4% in ASR hearts versus 26.4 +/- 4.1% and 25.0 +/- 2.6% in control organs, respectively. 5. The density (fmol/mg protein-1) of muscarinic receptors in membrane homogenates of hearts from SHR (127.6 +/- 11.5) was unchanged, whereas in hearts from ASR (221.0 +/- 8.9) it was found to be reduced (P < 0.05) when compared to the respective controls (142.5 +/- 14.7 and 308.8 +/- 16.1, respectively, all n = 6). 6. From the present data we conclude that cardiac hypertrophy results in a loss of sensitivity towards muscarinic receptor stimulation. A corresponding reduction of left ventricular receptor density could only be demonstrated in massively hypertrophied hearts of ASKeywords
This publication has 20 references indexed in Scilit:
- Depressed inotropic response to beta-adrenoceptor agonists in the presence of advanced cardiac hypertrophy in hearts from rats with induced aortic stenosis and from spontaneously hypertensive ratsJournal Of Hypertension, 1992
- Impaired inotropic response to ??1 but not to ??-adrenoceptor stimulation in isolated hearts from spontaneously hypertensive ratsJournal Of Hypertension, 1992
- Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophyAmerican Heart Journal, 1989
- A Different Desensitization Pattern of Cardiac β-Adrenoceptor Subtypes by Prolonged In Vivo Infusion of IsoprenalineJournal of Cardiovascular Pharmacology, 1989
- Muscarinic receptor differentiationPharmacology & Therapeutics, 1988
- Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonistLife Sciences, 1986
- Islet activating protein inhibits physiological responses evoked by cardiac muscarinic acetylcholine receptors. Role of guanosine triphosphate binding proteins in regulation of potassium permeabilityBiochemistry, 1985
- Comparison of β-adrenergic receptors and the adenylate cyclase system with muscarinic receptors and guanylate cyclase activities in the heart of spontaneously hypertensive ratsBiochemical Pharmacology, 1981
- The regulation of cardiac muscarinic cholinergic receptors by isoproterenolEuropean Journal of Pharmacology, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976